Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multifactorial Intervention in Type 2 Diabetes
NCT03430284Phase 4Unknown
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Apr 2018
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Integrated management rate of multiple risk factor in type 2 diabetes at 30 months and Incidence of diabetic vascular complications at 30 months. Status: unknown.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03430284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430284.